{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:09:57Z","timestamp":1793088597041,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T00:00:00Z","timestamp":1602374400000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jbspin.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:02:26Z","timestamp":1549825346000},"page":"589-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The management of osteogenesis imperfecta in adults: state of the art"],"prefix":"10.1016","volume":"86","author":[{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Courtois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.02.001_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajmg.a.33909","article-title":"Nosology and classification of genetic skeletal disorders: 2010 revision","volume":"155","author":"Warman","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0015","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164","author":"Van Dijk","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0020","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","article-title":"Osteoporosis in young adults: pathophysiology, diagnosis, and management","volume":"23","author":"Ferrari","year":"2012","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0025","unstructured":"Protocole National De Soins pour l\u2019Ost\u00e9og\u00e9n\u00e8se Imparfaite. https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2016-12\/pnds_-_osteogenese_imparfaite.pdf."},{"key":"10.1016\/j.jbspin.2019.02.001_bib0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13023-015-0362-2","article-title":"Initial report of the osteogenesis imperfecta adult natural history initiative","volume":"10","author":"Tosi","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/000348940211101014","article-title":"Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey","volume":"111","author":"Kuurila","year":"2002","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"10.1016\/j.jbspin.2019.02.001_bib0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/crj.12092","article-title":"Spinal deformities and lung function in adults with osteogenesis imperfecta","volume":"8","author":"Wekre","year":"2014","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000542-200210000-00039","article-title":"Osteogenesis imperfecta, perioperative bleeding, and desmopressin","volume":"97","author":"Keegan","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijcard.2016.09.107","article-title":"Cardiovascular disease in patients with osteogenesis imperfecta - a nationwide, register-based cohort study","volume":"225","author":"Folkestad","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0055","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/jp.2016.111","article-title":"Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study","volume":"36","author":"Ruiter-Ligeti","year":"2016","journal-title":"J Perinatol"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.14310\/horm.2002.1319","article-title":"The use of bisphosphonates in women prior to or during pregnancy and lactation","volume":"10","author":"Stathopoulos","year":"2011","journal-title":"Horm Athens Greece"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0065","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/jbmr.1555","article-title":"Prevalence and natural course of craniocervical junction anomalies during growth in patients with osteogenesis imperfecta","volume":"27","author":"Arponen","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0070","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00198-005-1905-5","article-title":"Musculoskeletal manifestations of mild osteogenesis imperfecta in the adult","volume":"16","author":"McKiernan","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jbmr.2920","article-title":"Fracture rates and fracture sites in patients with osteogenesis imperfecta: a nationwide register-based cohort study","volume":"32","author":"Folkestad","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3928\/01477447-20161006-04","article-title":"Challenges of fracture management for adults with osteogenesis imperfecta","volume":"40","author":"Gil","year":"2017","journal-title":"Orthopedics."},{"key":"10.1016\/j.jbspin.2019.02.001_bib0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00586-009-1197-0","article-title":"The role of kyphoplasty in the management of osteogenesis imperfecta: risk or benefit?","volume":"19","author":"F\u00fcrstenberg","year":"2010","journal-title":"Eur Spine J"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","article-title":"Intravenous neridronate in adults with osteogenesis imperfecta","volume":"18","author":"Adami","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-017-0236-9","article-title":"Long-term effects of neridronate in adults with osteogenesis imperfecta: an observational three-year Italian study","volume":"100","author":"Viapiana","year":"2017","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.jbspin.2019.02.001_bib0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00198-011-1658-2","article-title":"Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists","volume":"23","author":"Bradbury","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","article-title":"Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial","volume":"21","author":"Chevrel","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2012-4195","article-title":"The paradox of prevention--bilateral atypical subtrochanteric fractures due to bisphosphonates in osteogenesis imperfecta","volume":"98","author":"Manolopoulos","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.jbspin.2019.02.001_bib0115","first-page":"278","article-title":"An atypical fracture in male patient with osteogenesis imperfecta","volume":"12","author":"Etxebarria-Foronda","year":"2015","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4158\/EP14141.CR","article-title":"Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide","volume":"20","author":"Holm","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0125","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MJT.0000000000000236","article-title":"Efficacy of bisphosphonates on bone mineral density and fracture rate in patients with osteogenesis imperfecta: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","volume":"124","author":"Orwoll","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00223-013-9770-2","article-title":"Teriparatide treatment in adult patients with osteogenesis imperfecta type I","volume":"93","author":"Gatti","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0145","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jbmr.3143","article-title":"BPS804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized Phase 2a trial","volume":"32","author":"Glorieux","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1620\/tjem.242.115","article-title":"Efficacy of denosumab for osteoporosis in three female patients with osteogenesis imperfecta","volume":"242","author":"Uehara","year":"2017","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jbspin.2019.02.001_bib0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-017-0301-4","article-title":"Health-related quality of life in adults with osteogenesis imperfecta","volume":"101","author":"Hald","year":"2017","journal-title":"Calcif Tissue Int"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:24:23Z","timestamp":1761150263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19300223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1297319X19300223"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.02.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The management of osteogenesis imperfecta in adults: state of the art","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}